15 January 2019
|
open
Humanized anti-CD123 antibody facilitates NK cell antibody-dependent cell-mediated cytotoxicity (ADCC) of Hodgkin lymphoma targets via ARF6/PLD-1
Daniel Ernst, Brent A. Williams, Xing-Hua Wang, Nara Yoon, Kyung-Phil Kim, Jodi Chiu, Zhi Juan Luo, Karin G. Hermans, Joerg Krueger & Armand Keating
Blood Cancer Journal 9, 6
Research
|
14 January 2019
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Analysis of advanced cancer patients treated with immune-checkpoint inhibitors shows that tumor mutational burden, as assessed by targeted next-generation sequencing, predicts survival after immunotherapy across multiple cancer types.
Robert M. Samstein, Chung-Han Lee, Alexander N. Shoushtari, Matthew D. Hellmann, Ronglai Shen, Yelena Y. Janjigian, David A. Barron, Ahmet Zehir, Emmet J. Jordan, Antonio Omuro, Thomas J. Kaley, Sviatoslav M. Kendall, Robert J. Motzer, A. Ari Hakimi, Martin H. Voss, Paul Russo, Jonathan Rosenberg, Gopa Iyer, Bernard H. Bochner, Dean F. Bajorin, Hikmat A. Al-Ahmadie, Jamie E. Chaft, Charles M. Rudin, Gregory J. Riely, Shrujal Baxi, Alan L. Ho, Richard J. Wong, David G. Pfister, Jedd D. Wolchok, Christopher A. Barker, Philip H. Gutin, Cameron W. Brennan, Viviane Tabar, Ingo K. Mellinghoff, Lisa M. DeAngelis, Charlotte E. Ariyan, Nancy Lee, William D. Tap, Mrinal M. Gounder, Sandra P. D’Angelo, Leonard Saltz, Zsofia K. Stadler, Howard I. Scher, Jose Baselga, Pedram Razavi, Christopher A. Klebanoff, Rona Yaeger, Neil H. Segal, Geoffrey Y. Ku, Ronald P. DeMatteo, Marc Ladanyi, Naiyer A. Rizvi, Michael F. Berger, Nadeem Riaz, David B. Solit, Timothy A. Chan & Luc G. T. Morris
Nature Genetics, 1-5
Research
|
10 January 2019
|
open
Post-exposure immunotherapy for two ebolaviruses and Marburg virus in nonhuman primates
Current experimental monoclonal antibodies (mAbs) for Ebola virus (EBOV) post-exposure immunotherapy are ineffective against Sudan (SUDV) or Marburg virus (MARV). Here, authors develop cocktails of mAbs that protect nonhuman primates against EBOV, SUDV, and MARV infection when given four days post infection.
Jennifer M. Brannan, Shihua He, Katie A. Howell, Laura I. Prugar, Wenjun Zhu, Hong Vu, Sergey Shulenin, Shweta Kailasan, Henna Raina, Gary Wong, Md Niaz Rahim, Logan Banadyga, Kevin Tierney, Xuelian Zhao, Yuxing Li, Frederick W. Holtsberg, John M. Dye, Xiangguo Qiu & M. Javad Aman
Nature Communications 10, 105
Research
|
09 January 2019
Autologous CD19-directed chimeric antigen receptor-T cell is an effective and safe treatment to refractory or relapsed diffuse large B-cell lymphoma
Fang Bao, Wei Wan, Ting He, Feifei Qi, Guanghua Liu, Kai Hu, Xin-an Lu, Ping Yang, Fei Dong, Jing Wang & Hongmei Jing
Cancer Gene Therapy, 1-8
Research
|
09 January 2019
Intratumoral expression using a NFkB-based promoter enhances IL12 antitumor efficacy
Guillermo Garaulet, Gema Pérez-Chacon, Hernan Alarcón, Arantzazu Alfranca, Francisca Mulero, Jorge Martínez-Torrecuadrada, Juan M. Zapata & Antonio Rodríguez
Cancer Gene Therapy, 1-18
Reviews
|
04 January 2019
A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease
Potential disease-modifying therapies for Alzheimer disease have mostly targeted brain accumulation of amyloid-β, but this approach has yet to provide substantial clinical benefits. The authors consider the reasons for this failure and suggest alternative strategies, including modification of risk factors.
Francesco Panza, Madia Lozupone, Giancarlo Logroscino & Bruno P. Imbimbo
Nature Reviews Neurology, 1-16
All Research & Reviews
News and Comment
News
|
28 December 2018
Peanut allergy potential
Asher Mullard
Nature Reviews Drug Discovery 18, 7
News and Views
|
06 December 2018
The myriad targets of a T cell
Two methods for measuring cross-reactivity could boost the safety of T-cell therapies.
Aswin Natarajan & Michelle Krogsgaard
Nature Biotechnology 36, 1152-1154
Correspondence
|
05 December 2018
Donor lymphocyte infusion for BK virus hemorrhagic cystitis and nephropathy: a case report
Guillermo Ortí, Gloria Iacoboni, Pere Barba, Ramón Gimeno, Elisa Roldán, Laura Fox, Olga Salamero, Francesc Bosch & David Valcárcel
Bone Marrow Transplantation, 1-3
Correspondence
|
08 November 2018
|
open
Post-transplant immunotherapy with WT1-specific CTLs for high-risk acute myelogenous leukemia: a prospective clinical phase I/II trial
Hee-Je Kim, Hyun-Jung Sohn, Jung-A Hong, Hyun-Joo Lee, Dae-Hee Sohn, Chang-Ae Shin, Hyun-Il Cho, Woo-Sung Min & Tai-Gyu Kim
Bone Marrow Transplantation, 1-4
Correspondence
|
05 October 2018
Not so crystal clear: observations from a case of crystalline arthritis with cytokine release syndrome (CRS) after chimeric antigen receptor (CAR)-T cell therapy
Sarah H. Chung, Grant Hughes, Brian Koffman, Cameron J. Turtle, David G. Maloney & Utkarsh H. Acharya
Bone Marrow Transplantation, 1-3
Research Highlights
|
27 September 2018
Insights into the risk of fatal AEs with ICIs